Live Breaking News & Updates on Phase 1 Clinical Trial

Stay updated with breaking news from Phase 1 clinical trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2024 Earnings Call Transcript

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2024 Earnings Call Transcript February 7, 2024 Viking Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this […] ....

United States , Obesity Week , Annual Meeting , American Association , Quality Tea Brands , Quality Bed Sheets , Viking Therapeutics , Viking Therapeutics , Phase 1 Clinical Trial , Clinical Programs , Clinical Trial , Stephanie Diaz , Greg Zante , Thyroid Hormone Receptor ,

Onward Therapeutics Announces Enrollment of Phase 1 Clinical Trial of a Novel Bispecific Antibody (OT-A201) Targeting Two Immune Checkpoints

Onward Therapeutics SA (Onward Therapeutics), a global biotechnology company focused on developing innovative immunotherapies for cancer treatment, today announced that the phase 1 clinical trial of OT-A201 (Study No. A20101), a first-in-class bispecific antibody targeting two immune checkpoints is in progress. ....

Switzerland General , France General , T Ai Pei , Alain Herrera , Biomunex Pharmaceuticals , Onward Therapeutics , Chief Medical , Bispecific Antibody , Hematological Malignancies , Phase 1 Clinical Trial , Immune Checkpoints , Iopharmaceutical Company , Biomunex Pharmaceuticals , Drug Development , Solid Tumors , Cancer Treatment ,

United States Clinical Trial Data Management Service Market

Dublin, Nov. 21, 2023 (GLOBE NEWSWIRE) The ....

United States , Cromos Pharma , Biotech Pharmaceutical Companies , Us Clinical Trial Data Management Service Market , Service Companies , Trial Data Management Service Market , Market Value , Fisher Scientific , Research And Markets , Contract Research Organization , Data Management , Ata Storage And Management , Phase 1 Clinical Trial , Phase 3 Clinical Trial ,

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q3 2023 Earnings Call Transcript

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q3 2023 Earnings Call Transcript November 13, 2023 Biora Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-4.89 EPS, expectations were $-0.93. Operator: Greetings and welcome to the Biora Therapeutics Third Quarter 2023 earnings call. At this time, all participants are in a listen only mode. A brief question-and-answer session […] ....

Adi Mohanty , Joe Pantginis , Ann Arbor , Focused Hedge Funds , Chuck Pedala , Phase 1 Clinical Trial , Perator Instructions , Forward Looking Statements , R Mohanty , Adi Mohanty ,

Terns Pharmaceuticals Inc (TERN) Reports Q3 2023 Financials and Corporate Progress

Advancements in Clinical Trials and Strong Cash Position Highlighted ....

Senthil Sundaram , Terns Pharmaceuticals Inc , Erin Quirk , New Drug , Pharmaceuticals Inc , Phase 1 Clinical Trial , Terns Pharmaceuticals Inc , Clinical Trial , Trial Results , Cash Reserves ,